AG
AMRI

Advisor Group’s Albany Molecular Research Inc AMRI Stock Holding History

Advisor Group’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-317
Closed -$7K – 5087
2017
Q2 		$7K Sell
317
-190
-37% -$3.45K ﹤0.01% 4136
2017
Q1 		$7K Buy
507
+172
+51% +$2.82K ﹤0.01% 4003
2016
Q4 		$6K Sell
335
-903
-73% -$15.3K ﹤0.01% 3893
2016
Q3 		$20K Buy
1,238
+145
+13% +$2.15K ﹤0.01% 3167
2016
Q2 		$14K Buy
+1,093
New +$15.9K ﹤0.01% 3310

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Advisor Group's AMRI Position: Q3 2017 in Review

Advisor Group sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 317 shares — an estimated $7K sold.

Advisor Group first reported a position in AMRI in Q2 2016 and held it in 5 quarters. The position peaked at $20K in Q3 2016. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Advisor Group reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Advisor Group sold 317 Albany Molecular Research Inc shares in Q3 2017, an estimated $7K.
  • Advisor Group first reported a position in Albany Molecular Research Inc in Q2 2016 and held it in 5 quarters.
  • Advisor Group's Albany Molecular Research Inc position peaked at $20K in Q3 2016.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Advisor Group's 13F filing for Q3 2017, filed 6 Nov 2017.